Orphanix Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

Orphanix General Information

Description

Developer of drugs designed to treat rare diseases. The company formulates drugs for diseases that are not very common among humans, enabling clinicians to solve a high unmet medical need in the pediatric orphan drug space.

Contact Information

Website
www.orphanix.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Lederergasse 18/1
  • Linz, 4020
  • Austria
Primary Industry
Drug Discovery
Vertical(s)
HealthTech
Corporate Office
  • Lederergasse 18/1
  • Linz, 4020
  • Austria

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphanix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 15-Jun-2015 Completed Generating Revenue
To view Orphanix’s complete valuation and funding history, request access »

Orphanix Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Orphanix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3880168-A1 Aqueous paediatric retinol formulations Active 26-Nov-2018 000000000
US-20220000802-A1 Aqueous paediatric retinol formulations Pending 26-Nov-2018 0000000000 0
CA-3117767-A1 Aqueous paediatric retinol formulations Pending 26-Nov-2018 000000000
AU-2019386241-A1 Aqueous paediatric retinol formulations Pending 26-Nov-2018 000000000
EP-3880168-B1 Aqueous paediatric retinol formulations Active 26-Nov-2018 A61K31/07
To view Orphanix’s complete patent history, request access »

Orphanix Executive Team (2)

Name Title Board Seat
Philipp Novak Co-Founder, Chief Executive Officer & Managing Director
Stefan Johansson Ph.D Co-Founder & Chief Medical Officer
To view Orphanix’s complete executive team members history, request access »

Ready to get started?

Request a free trial

Orphanix FAQs

  • When was Orphanix founded?

    Orphanix was founded in 2015.

  • Who is the founder of Orphanix?

    Philipp Novak and Stefan Johansson Ph.D are the founders of Orphanix.

  • Who is the CEO of Orphanix?

    Philipp Novak is the CEO of Orphanix.

  • Where is Orphanix headquartered?

    Orphanix is headquartered in Linz, Austria.

  • What industry is Orphanix in?

    Orphanix’s primary industry is Drug Discovery.

  • Is Orphanix a private or public company?

    Orphanix is a Private company.

  • What is Orphanix’s current revenue?

    The current revenue for Orphanix is 00000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »